Mosanna Therapeutics Funding: $80M Raised, Series A (2025)
Mosanna Therapeutics is a Biotech company based in Redwood City, CA. It has raised $80M in total funding. Latest round: Series A.
Mosanna Therapeutics funding overview
Mosanna Therapeutics is a Biotech company based in Redwood City, CA. Mosanna Therapeutics has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Mosanna Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Pivotal bioVenture Partners, EQT Life Sciences, Forbion, Broadview Ventures, Norwest, Forty51 Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Frequently asked about Mosanna Therapeutics funding
How much has Mosanna Therapeutics raised?
Mosanna Therapeutics has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Mosanna Therapeutics?
Pivotal bioVenture Partners, EQT Life Sciences, Forbion, Broadview Ventures, Norwest, Forty51 Ventures are named among the investors backing Mosanna Therapeutics.
What was the latest Mosanna Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Mosanna Therapeutics based?
Mosanna Therapeutics is based in Redwood City, CA.
What sector does Mosanna Therapeutics operate in?
Mosanna Therapeutics is tracked under Biotech from Redwood City, CA, with $80M in disclosed funding.
When did Mosanna Therapeutics last raise?
The last disclosed Mosanna Therapeutics round closed in January 2025 at Series A.
Every Mosanna Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Redwood City at a similar stage.
